Charles J. Filipi

SafeStitch Medical, Inc. operates as a developmental stage FDA-registered medical device company, which is focused on the development of medical devices that manipulate tissues for the treatment of obesity, gastroesophageal reflux disease, hernia formation, esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery. It products include AMID Stapler, SMART Dilator, and standard and airway bite blocks. AMID Stapler is used to fix mesh in place, which helps prevent the recurrence of a hernia. SMART Dilators are used when an endoscopy demonstrates the narrowing of the esophagus. The bite blocks are used to protect the endoscope used in transoral gastrointestinal procedures and are required in all such procedures. SafeStitch Medical was founded by Charles J. Filip and Jeffrey G. Spragens in August 1988 and is headquartered in Miami, FL.

The Group's principal activity is to merge, consolidation, reorganization, joint venture or licensing agreement with another corporation or entity. The Group is seeking opportunity with one or more firms which have recently commenced operations, or which wish to utilize the public marketplace in order to raise additional capital in order to expand into new products or markets, to develop a new product or service or for other corporate purposes.

Part of Asensus Surgical, Inc., SafeStitch LLC is a company that develops endoscopic medical devices. The company is based in Omaha, NE. The company was founded by Charles J. Filipi, Jeffrey G. Spragens. SafeStitch was acquired by Cellular Technical Services Co., Inc. on September 05, 2007 for $28.70 million.

Americas Hernia Society engages in the exchange of information and education regarding diagnosis and treatment of abdominal wall abnormalities. The company was founded in 1997 and is headquartered in Denver, CO.